Cargando…

Urea levels and cardiovascular disease in patients with chronic kidney disease

BACKGROUND: Elevated serum urea levels are common in moderate-to-advanced chronic kidney disease (CKD). Several studies have shown that urea is a direct and indirect uraemic toxin, especially with regard to cardiovascular disease. We sought to determine whether serum urea levels are associated with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laville, Solène M, Couturier, Aymeric, Lambert, Oriane, Metzger, Marie, Mansencal, Nicolas, Jacquelinet, Christian, Laville, Maurice, Frimat, Luc, Fouque, Denis, Combe, Christian, Robinson, Bruce M, Stengel, Bénédicte, Liabeuf, Sophie, Massy, Ziad A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869852/ https://www.ncbi.nlm.nih.gov/pubmed/35544273 http://dx.doi.org/10.1093/ndt/gfac045

Ejemplares similares

Consequences of oral antithrombotic use in patients with chronic kidney disease
por: Laville, Solène M., et al.
Publicado: (2021)

Impact of age on cardiovascular drug use in patients with chronic kidney disease
por: Villain, Cédric, et al.
Publicado: (2019)

Proton-Pump Inhibitors and Serum Concentrations of Uremic Toxins in Patients with Chronic Kidney Disease
por: El Chamieh, Carolla, et al.
Publicado: (2023)

Longitudinal uric acid has nonlinear association with kidney failure and mortality in chronic kidney disease
por: Prezelin-Reydit, Mathilde, et al.
Publicado: (2023)

Probiotic Intake and Inflammation in Patients With Chronic Kidney Disease: An Analysis of the CKD-REIN Cohort
por: Wagner, Sandra, et al.
Publicado: (2022)

Urinary Sodium-to-Potassium Ratio and Blood Pressure in CKD
por: Alencar de Pinho, Natalia, et al.
Publicado: (2020)

The French Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) cohort study
por: Stengel, Bénédicte, et al.
Publicado: (2014)

Intestinal Chelators, Sorbants, and Gut-Derived Uremic Toxins
por: Laville, Solène M., et al.
Publicado: (2021)

Prediction of chronic kidney disease after acute kidney injury in ICU patients: study protocol for the PREDICT multicenter prospective observational study
por: Geri, Guillaume, et al.
Publicado: (2018)

Prescription of Direct Oral Anticoagulants to Patients With Moderate-to-Advanced CKD: Too Little or Just Right?
por: Liabeuf, Sophie, et al.
Publicado: (2021)

Difference in Profiles of the Gut-Derived Tryptophan Metabolite Indole Acetic Acid between Transplanted and Non-Transplanted Patients with Chronic Kidney Disease
por: Liabeuf, Sophie, et al.
Publicado: (2020)

Vascular access conversion and patient outcome after hemodialysis initiation with a nonfunctional arteriovenous access: a prospective registry-based study
por: Alencar de Pinho, Natalia, et al.
Publicado: (2017)

Predictors of nonfunctional arteriovenous access at hemodialysis initiation and timing of access creation: A registry-based study
por: Alencar de Pinho, Natalia, et al.
Publicado: (2017)

Effects of the dialysate calcium concentrations and mineral bone disease treatments on mortality in The French Renal Epidemiology and Information Network (REIN) registry
por: Lambert, Oriane, et al.
Publicado: (2020)

The Public Health Burden of Cardiomyopathies: Insights from a Nationwide Inpatient Study
por: Lannou, Simon, et al.
Publicado: (2020)

Serum Calcification Propensity Represents a Good Biomarker of Vascular Calcification: A Systematic Review
por: Pluquet, Maxime, et al.
Publicado: (2022)

Practice patterns of dialysis access and outcomes in patients wait-listed early for kidney transplantation
por: Sylvestre, Raphaëlle, et al.
Publicado: (2020)

Should We Use Standard Survival Models or the Illness-Death Model for Interval-Censored Data to Investigate Risk Factors of Chronic Kidney Disease Progression?
por: Boucquemont, Julie, et al.
Publicado: (2014)

Achievement of Low-Density Lipoprotein Cholesterol Targets in CKD
por: Massy, Ziad A., et al.
Publicado: (2019)

Acute kidney injury associated with febuxostat and allopurinol: a post-marketing study
por: Rey, Amayelle, et al.
Publicado: (2019)

Hypertension Control, Apparent Treatment Resistance, and Outcomes in the Elderly Population With Chronic Kidney Disease
por: Kaboré, Jean, et al.
Publicado: (2016)

Uremic Toxins and Cardiovascular Risk in Chronic Kidney Disease: What Have We Learned Recently beyond the Past Findings?
por: El Chamieh, Carolla, et al.
Publicado: (2022)

Fetal and Neonatal Adverse Drug Reactions Associated with Biologics Taken During Pregnancy by Women with Autoimmune Diseases: Insights from an Analysis of the World Health Organization Pharmacovigilance Database (VigiBase(®))
por: Dernoncourt, Amandine, et al.
Publicado: (2022)

A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guidelines on Acute Kidney Injury: Part 1: definitions, conservative management and contrast-induced nephropathy(†)
por: Fliser, Danilo, et al.
Publicado: (2012)

Evaluation of Changes Over Time in the Drug Burden and Medication Regimen Complexity in ESRD Patients Before and After Renal Transplantation
por: Marienne, Justine, et al.
Publicado: (2020)

From old uraemic toxins to new uraemic toxins: place of ‘omics’
por: Massy, Ziad A, et al.
Publicado: (2018)

Kidney Function Decline and Apparent Treatment-Resistant Hypertension in the Elderly
por: Kaboré, Jean, et al.
Publicado: (2016)

Does kidney transplantation influence a form of discrimination for antihypertensive drugs prescriptions?
por: Cheddani, Lynda, et al.
Publicado: (2021)

Association of plasma potassium with mortality and end-stage kidney disease in patients with chronic kidney disease under nephrologist care - The NephroTest study
por: Wagner, Sandra, et al.
Publicado: (2017)

Correction to: Association of plasma potassium with mortality and end-stage kidney disease in patients with chronic kidney disease under nephrologist care - The NephroTest study
por: Wagner, Sandra, et al.
Publicado: (2017)

Uremic Toxins and Clinical Outcomes: The Impact of Kidney Transplantation
por: Liabeuf, Sophie, et al.
Publicado: (2018)

Association between Free Light Chain Levels, and Disease Progression and Mortality in Chronic Kidney Disease
por: Desjardins, Lucie, et al.
Publicado: (2013)

Adherence to the Kidney Disease: Improving Global Outcomes CKD Guideline in Nephrology Practice Across Countries
por: Stengel, Bénédicte, et al.
Publicado: (2020)

The Authors Reply
por: Alencar de Pinho, Natalia, et al.
Publicado: (2020)

Protein-Bound Uremic Toxins: New Insight from Clinical Studies
por: Liabeuf, Sophie, et al.
Publicado: (2011)

Drugs associated with incident fragility fractures in kidney transplant recipients
por: Batteux, Benjamin, et al.
Publicado: (2022)

Switching to lanthanum carbonate monotherapy provides effective phosphate control with a low tablet burden
por: Hutchison, Alastair J., et al.
Publicado: (2008)

Day-Time Declamping Is Associated with Better Outcomes in Kidney Transplantation: The Circarein Study
por: Montaigne, David, et al.
Publicado: (2021)

Prescription of renin‐angiotensin‐aldosterone system inhibitors (RAASi) and its determinants in patients with advanced CKD under nephrologist care
por: Pecoits‐Filho, Roberto, et al.
Publicado: (2019)

The Addition of Vascular Calcification Scores to Traditional Risk Factors Improves Cardiovascular Risk Assessment in Patients with Chronic Kidney Disease
por: Liabeuf, Sophie, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_urajosooftn4m2h5do9ot5gub2